John Gary Potthoff

John Gary Potthoff is the founder of Elligo Health Research, Inc., founded in 2016, serving as Chairman since 2023.
Current jobs include Chief Executive Officer & Director at Regulatory & Quality Solutions LLC since 2021, Chief Executive Officer at RQM+ Corp.
since 2024, Board of Director at Chembio Diagnostic Systems, Inc. since 2018, Advisor at Excelerate Health Ventures LLC, and Operating Partner at Linden Manager LLC starting in 2025.
Former jobs include President & Chief Executive Officer at Tanistry, Inc. from 2000 to 2001, President & Chief Executive Officer at Theorem Clinical Research, Inc. from 2011 to 2015, Executive Director at Pharmaceutical Product Development LLC from 1993 to 2001, Director at Chembio Diagnostics, Inc. from 2018 to 2023, board of Director at Chiltern International Ltd. from 2015 to 2017, Board of Director at Chesapeake Research Review LLC from 2016 to 2019, Board of Director at SynteractHCR Holdings Corp.
from 2017 to 2020, Director at Labcorp International Group Ltd., Director at Advarra, Inc., Chief Operating Officer at Syneos Health NC LLC, Principal at The University of Texas at Austin, Senior Advisor at Amulet Capital Partners LP, and Chief Operating Officer at INC Research Holdings, Inc. from 2001 to 2010.
Education includes undergraduate degree conferred in 1989, graduate degree in 1992, and doctorate in 1995 from The University of Texas at Austin.